Nautilus Biotechnology, Inc.

Historical 13F Holders

Symbol
NAUT
CUSIP
63909J108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 63909J108 since 12/18/2024, largest first.

Filer % of Class Filed
Parag Mallick 13D/A 17.6% 3/4/2026
Event 3/2/2026
Patel Sujal M 13D/A 16.3% 3/4/2026
Event 3/2/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
AH Bio Fund II, L.P. 13D/A
4.9% 9/11/2026
Event 9/9/2026
Perceptive Advisors LLC 13D/A
3.9% 11/3/2026
Event 10/5/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 89 43.0 M $61.1M
2026 Q2 94 50.2 M $93.7M
2026 Q1 83 54.3 M $211M
2025 Q4 68 58.4 M $114M
2025 Q3 68 57.9 M $48.9M
2025 Q2 72 59.8 M $43.3M
2025 Q1 89 62.8 M $54.0M
2024 Q4 89 63.9 M $107M
2024 Q3 84 64.2 M $183M
2024 Q2 79 64.0 M $150M
2024 Q1 74 63.2 M $186M
2023 Q4 77 63.4 M $190M
2023 Q3 77 45.1 M $142M
2023 Q2 76 44.8 M $173M
2023 Q1 75 44.5 M $123M
2022 Q4 82 46.1 M $82.9M
2022 Q3 87 56.4 M $120M
2022 Q2 84 57.5 M $155M
2022 Q1 83 56.0 M $244M
2021 Q4 83 59.6 M $235M
2021 Q3 73 41.0 M $245M
2021 Q2 59 39.0 M $380M